Privia Health (PRVA) Enterprise Value (2020 - 2026)

Privia Health's Enterprise Value history runs 7 years deep, the most recent figure standing at -$366.7 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 12.54% year-over-year to -$366.7 million in Q1 2026; TTM through Mar 2026 was -$366.7 million, a 12.54% increase from a year earlier, with the FY2025 full-year figure at -$426.0 million, up 3.82% from the prior year.
• Enterprise Value improved to -$366.7 million in Q1 2026 per PRVA's latest filing, from -$426.0 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$268.0 million in Q1 2023 and bottomed at -$442.9 million in Q4 2024.
• The 5-year median for Enterprise Value is -$339.2 million (2024), against an average of -$338.6 million.
• Biggest YoY gain for Enterprise Value was 19.5% in 2022; the steepest drop was 245.54% in 2022.
• Year by year, Enterprise Value stood at -$328.0 million in 2022, then retreated by 4.73% to -$343.6 million in 2023, then dropped by 28.91% to -$442.9 million in 2024, then increased by 3.82% to -$426.0 million in 2025, then increased by 13.92% to -$366.7 million in 2026.
• Per Business Quant, the three latest PRVA Enterprise Value figures stand at -$366.7 million (Q1 2026), -$426.0 million (Q4 2025), and -$387.7 million (Q3 2025).